Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / KROS - Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board

KROS - Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board

Keros Therapeutics Inc.
  • BeiGene began trading on the Shanghai STAR Board as the last step in its $3.5 billion IPO. The company is now listed in the US, Hong Kong and Shanghai.
  • Jinan Qilu Pharma entered a $300 million agreement to acquire greater China rights to an RNAi therapy for hepatitis B developed by Arbutus Bio.
  • Jiangsu Hansoh Pharma acquired China rights to a novel cytopenia therapy from Keros Therapeutics in a $190 million agreement.
  • Shanghai Everest Medicines partnered with Providence Therapeutics, an Alberta company, to develop a new COVID-19 vaccine that targets the Omicron variant.

For further details see:

Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board
Stock Information
Company Name: Keros Therapeutics Inc.
Stock Symbol: KROS
Market: NASDAQ
Website: kerostx.com
Menu
KROS KROS Quote KROS Short KROS News KROS Articles KROS Message Board
Get KROS Alerts

News, Short Squeeze, Breakout and More Instantly...